Jeena Sikho Lifecare (JSLL) Investor presentation summary

Business model and network

• Integrated care combines Ayurveda, Panchakarma, Homeopathy and Naturopathy, supported by 200+ doctors and 300+ Shuddhi-branded herbal and Ayurvedic products.

• Pan-India network totaled 119 sites as of June 30, 2023: 14 HIIMS hospitals, 21 Panchkarma day-care clinics, 80 Shuddhi clinics and 4 franchise clinics.

• 17 clinics held NABH accreditation; expansion was concentrated in North, Central, East and West India, with entry into Southern states underway.

• Asset-light model uses leased premises, owned and franchise clinics, and low setup costs; per-bed hospital setup cost ranges from ₹2 lakh to ₹2.5 lakh.

Services and technology

• Offerings span inpatient and outpatient care, day care, Panchakarma, personalized diet care, home-based support, consultations and lifestyle guidance.

• Care model covers prevention, corrective treatment and post-treatment maintenance, with follow-ups and monitoring for sustained health goals.

• Dedicated contact centre supports order placement, consumer queries, clinic and hospital connections, insurance guidance, and virtual or telephone consultations.

• Digital platform includes online bookings, patient and medicine-order tracking, video consultations, CRM, analytics, communications tools and information-security controls.

Growth strategy and market opportunity

• Expansion priorities include domestic reach, brand recognition, a wider consumer base, cost management, international growth evaluation and leveraging management expertise.

• 20 hospitals and clinics opened in FY22-23, compared with 8 in FY21-22; the network also includes a 1,000-bed HIIMS hospital in Meerut and an MoU for a hospital in Vietnam.

• Strategy targets growth in healthcare services alongside products, South India expansion, government partnerships and an asset-light mix of owned and franchise locations.

• India’s Ayurvedic products market was cited as expected to grow at ~15% CAGR in 2021-2026; the Ayurveda market was projected at US$10 billion by 2024, from US$4 billion in 2018.